| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/25/2009 | US7579344 Pyrimidine derivatives possessing cell-cycle inhibitors activity |
| 08/25/2009 | CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/25/2009 | CA2327673C Aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 08/20/2009 | WO2009102937A1 Processes for the preparation of carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/20/2009 | WO2009102016A1 Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device |
| 08/20/2009 | WO2009101823A1 Branched compounds, organic thin films made by using the same, and organic thin film devices |
| 08/20/2009 | WO2009101345A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 08/20/2009 | WO2009101185A2 A polymorphic form of a pyrazino [2, 3-h] [3] benzazepine derivative |
| 08/20/2009 | WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | WO2009100655A1 The aromatic ring triazine derivatives and the uses thereof |
| 08/20/2009 | WO2009100536A1 Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures |
| 08/20/2009 | WO2009082268A3 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
| 08/20/2009 | US20090209764 Process for Preparation of 4-amino-1-isobutyl-1H-Imidazo[4,5-C]-quinoline (Imiquimod) |
| 08/20/2009 | US20090209757 High purity; reacting paliperidone with palmitic anhydride, a pyridine derivative and solvent; palmitic anhydride made from pure palmitic acid |
| 08/20/2009 | US20090209578 Chemical compounds |
| 08/20/2009 | US20090209577 Novel Triazolopyridine Compounds |
| 08/20/2009 | US20090209571 Phenanthrene derivatives as MPGES-1 inhibitors |
| 08/20/2009 | US20090209566 Spirocyclic Compounds |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209547 C-8 halogenated macrolides |
| 08/20/2009 | US20090209546 L-Malate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 08/20/2009 | US20090209544 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 08/20/2009 | US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 08/20/2009 | US20090209540 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same |
| 08/20/2009 | US20090209531 used for treating metabolic, nervous sytsem and skin disorders,inflammatory diseases, obesity, cachexia, erectile dysfunction, neuropathic pain, or as antidepressants, anxiolytic and anticarcinogenic agents |
| 08/20/2009 | US20090208456 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
| 08/20/2009 | US20090208413 Registry Method and Control System for Dea Schedule II-V Medicines |
| 08/20/2009 | US20090206731 Rigid Amines |
| 08/20/2009 | CA2715138A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
| 08/20/2009 | CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/19/2009 | EP2090577A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 08/19/2009 | EP2090576A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| 08/19/2009 | EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2089390A1 Heptarylene and octarylene tetracarboxylic acid diimides, and production thereof |
| 08/19/2009 | EP2089389A2 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
| 08/19/2009 | EP2089388A2 Process for the synthesis of moxifloxacin hydrochloride |
| 08/19/2009 | EP2089387A1 Indolizine derivatives and their use as antidiabetics |
| 08/19/2009 | EP2089384A2 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/19/2009 | EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists |
| 08/19/2009 | EP1937679B1 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 08/19/2009 | EP1740585B1 Enantiomer-pure hexahydropyrrolocyclopentapyridine derivatives |
| 08/19/2009 | EP1648864A4 Photochromic diarylethene-containing coordination compounds and the production thereof |
| 08/19/2009 | EP1615645B1 A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for the preparation thereof |
| 08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/19/2009 | CN101511830A Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine |
| 08/19/2009 | CN101511829A Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 08/19/2009 | CN101511828A Heteroaryl derivatives as protein kinase inhibitors |
| 08/19/2009 | CN101511190A Pressure sensor fault detection |
| 08/19/2009 | CN101510590A Organic electroluminescent element and display |
| 08/19/2009 | CN101508893A 1,4,5,8-naphthalenetetracarboxylic imide derivative bifluorescent material and method of preparing the same |
| 08/19/2009 | CN101508695A Indolizine-peptide piperazine diketone derivatives, preparation and antimicrobial uses thereof |
| 08/19/2009 | CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 08/19/2009 | CN100528873C 3 position substituted mesoazalene compounds and high efficiency synthesis method |
| 08/19/2009 | CN100528866C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576214 Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1,8-naphthyridine-3-carboxylic acid |
| 08/18/2009 | US7576209 Breast, prostate and ovarian cancer; such as 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine; serine/threonine kinase (Akt) suppression |
| 08/18/2009 | US7576208 Organic semiconductor layers |
| 08/18/2009 | US7576095 2-(p-Alkoxy- or p-fluoroalkylsulonyloxyphenyl)-1-phenyl-5-cyclohexyl- or 5-(1-piperdinyl)-4,5-dihydropyrrolo[3,2-c]pyridin-4-ones; treatment of obesity, psychiatric and neurological disorders |
| 08/18/2009 | US7576092 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 08/18/2009 | US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576085 Imidazo[1,2-a]pyrazine compounds; cancers |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | US7575902 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases |
| 08/18/2009 | CA2495721C Non-nucleoside reverse transcriptase inhibitors |
| 08/18/2009 | CA2479216C Dipyridodiazepinones as reverse transcriptase inhibitors |
| 08/18/2009 | CA2429133C Novel imidazole derivatives, production method thereof and use thereof |
| 08/18/2009 | CA2427831C Cyclization process step in the making of quinolones and naphthyridines |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/13/2009 | WO2009099982A1 2-aminopyridine kinase inhibitors |
| 08/13/2009 | WO2009099929A1 Mesoionic pesticides |
| 08/13/2009 | WO2009099801A1 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 08/13/2009 | WO2009098283A1 (dihydro)pyrrolo[2,1-a]isoquinolines |
| 08/13/2009 | WO2009098252A1 Perylene semiconductors and methods of preparation and use thereof |
| 08/13/2009 | WO2009074575A3 Organic compounds |
| 08/13/2009 | WO2009034475A3 Perharidines as cdk inhibitors |
| 08/13/2009 | WO2009032754A3 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 08/13/2009 | US20090203912 Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 08/13/2009 | US20090203730 Bicyclic ppat inhibitors as antibacterial agents |
| 08/13/2009 | US20090203715 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 08/13/2009 | US20090203702 INHIBITORS OF p38 |
| 08/13/2009 | US20090203694 Inhibitors of undecaprenyl pyrophosphate synthase |
| 08/13/2009 | US20090203677 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/13/2009 | US20090203673 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments |
| 08/13/2009 | US20090203668 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/13/2009 | US20090203665 Heterocyclic-substituted phenyl methanones |
| 08/13/2009 | US20090203657 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/13/2009 | CA2714423A1 Perylene semiconductors and methods of preparation and use thereof |
| 08/13/2009 | CA2714419A1 Dual pharmacophores - pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714418A1 Dual pharmacophores - pde4 -muscarinic antagonistics |
| 08/13/2009 | CA2714352A1 Dual pharmacophores-pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714181A1 Ampk modulators |